Trulieve Cannabis Corp. SEC filings TRLV

Trulieve Cannabis Corp. has 416 filings in SEC EDGAR's recent list, going back to Oct 2, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Trulieve Cannabis Corp. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
S-8 POS Filing Aug 24, 2026 —
POSASR Filing Aug 24, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Aug 11, 2026 Aug 11, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Aug 7, 2026 Aug 7, 2026
8-K Current report
Shareholder vote results
Aug 5, 2026 Aug 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 8, 2026 —
8-K Current report
Officer or director change
Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
DEF 14A Proxy statement Jun 25, 2026 Jun 25, 2026
DEFA14A Additional proxy material Jun 25, 2026 —
4 Insider transaction Jun 22, 2026 Jun 17, 2026
144 Notice of proposed sale Jun 17, 2026 —
PRE 14A Preliminary proxy statement Jun 12, 2026 Jun 8, 2026
8-K Current report
Officer or director change
Jun 12, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 9, 2026
CERT Nyse certification Jun 9, 2026 —
8-K Current report
Other events
Jun 9, 2026 Jun 9, 2026
8-A12B Filing Jun 9, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets
Jun 4, 2026 Jun 3, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
DEFA14A Additional proxy material Apr 29, 2026 —
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 29, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Apr 21, 2026 Apr 15, 2026
4 Insider transaction Mar 17, 2026 Mar 3, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
3 Initial insider ownership Mar 10, 2026 Feb 28, 2026
8-K Current report
Officer or director change
Mar 5, 2026 Feb 27, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
8-K Current report
Officer or director change
Feb 18, 2026 Feb 12, 2026
D Filing Feb 6, 2026 —
8-K Current report
Material agreement, New debt, Other events
Jan 29, 2026 Jan 29, 2026
3 Initial insider ownership Jan 27, 2026 Jan 14, 2026
D Filing Dec 29, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 18, 2025 —
8-K Current report
Material agreement, New debt, Other events
Dec 17, 2025 Dec 17, 2025
8-K Current report
Other events
Dec 9, 2025 Dec 8, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Dec 8, 2025 Dec 1, 2025
4 Insider transaction Nov 5, 2025 Nov 4, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Other events
Nov 4, 2025 Nov 4, 2025
3 Initial insider ownership Sep 30, 2025 Sep 8, 2025
3 Initial insider ownership Sep 3, 2025 Aug 27, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 27, 2025 Aug 27, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Aug 12, 2025
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
S-3ASR Automatic shelf registration Jun 30, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 12, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2025 May 7, 2025
DEFR14A Filing Apr 30, 2025 —
DEFA14A Additional proxy material Apr 29, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 29, 2025 Dec 31, 2024
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
4 Insider transaction Mar 28, 2025 Mar 25, 2025
3 Initial insider ownership Mar 11, 2025 Mar 6, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 7, 2025 Mar 6, 2025
3 Initial insider ownership Mar 5, 2025 Feb 26, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
4 Insider transaction Dec 31, 2024 Dec 29, 2024
4 Insider transaction Dec 31, 2024 Dec 29, 2024
4 Insider transaction Dec 31, 2024 Dec 29, 2024
4 Insider transaction Dec 31, 2024 Dec 29, 2024
4 Insider transaction Dec 31, 2024 Dec 29, 2024
4 Insider transaction Dec 31, 2024 Dec 29, 2024
4 Insider transaction Dec 13, 2024 Dec 11, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Dec 3, 2024 Dec 1, 2024
4 Insider transaction Nov 21, 2024 Nov 21, 2024
4 Insider transaction Nov 21, 2024 Nov 21, 2024
4 Insider transaction Nov 21, 2024 Nov 21, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
4 Insider transaction Nov 21, 2024 Nov 20, 2024
4 Insider transaction Nov 21, 2024 Nov 12, 2024
3 Initial insider ownership Nov 21, 2024 Jul 17, 2024
4 Insider transaction Nov 19, 2024 Nov 15, 2024
4 Insider transaction Nov 18, 2024 Nov 15, 2024
4 Insider transaction Nov 14, 2024 Nov 13, 2024
4 Insider transaction Nov 14, 2024 Nov 8, 2024
3 Initial insider ownership Nov 14, 2024 Jul 17, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4/A Primary document Nov 13, 2024 Mar 8, 2024
4 Insider transaction Nov 13, 2024 Nov 8, 2024
4 Insider transaction Nov 13, 2024 Nov 11, 2024
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2024 Nov 5, 2024
SC 13G/A Amended ownership over 5% (passive) Sep 18, 2024 —
4 Insider transaction Sep 17, 2024 Sep 16, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2024 Aug 6, 2024
S-8 Employee stock plan registration Jun 21, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2024 Jun 12, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 17, 2024 May 16, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 30, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 30, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Apr 23, 2024 Apr 17, 2024
8-K Current report
Auditor change
Mar 29, 2024 Mar 25, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 29, 2024 Feb 29, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
3 Initial insider ownership Feb 5, 2024 Jan 29, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 18, 2024 Jan 17, 2024
4 Insider transaction Jan 16, 2024 Dec 29, 2023
4 Insider transaction Jan 16, 2024 Dec 29, 2023
4 Insider transaction Jan 16, 2024 Dec 29, 2023
4 Insider transaction Jan 16, 2024 Dec 29, 2023
4 Insider transaction Jan 16, 2024 Dec 29, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023
4/A Form 4/a submission Jan 16, 2024 Jul 25, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
TRLV (NYSE)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Tallahassee, FL
SEC filer status
Large accelerated filer
SEC CIK
1754195

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.